Skip to NavigationSkip to content

FDA greenlights Teva's migraine drug Ajovy in two dosage options

Published on 20/09/18 at 10:16am

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a preventative treatment for migraine in both monthly and quarterly doses.

The drug, which the manufacturer claims is the first of its kind to secure approval across the two dosing groups, reduced monthly migraine days experienced by participants with disabling migraine over 12 weeks, both as a monotherapy and in combination with  oral preventative treatments.

“Migraine is a disabling neurological disease that affects more than 36 million people in the United States,” commented Dr Stephen Silberstein, Director, Jefferson Headache Center at Thomas Jefferson University Hospital, and lead investigator of the Phase III clinical trial programme for Ajovy. “About 40% of people living with this condition may be appropriate candidates for preventive treatment, yet the majority of them are untreated. I am pleased to have another treatment option that may allow my patients to experience fewer monthly migraine days.”

Ajovy’s wholesale acquisition cost in the US stands at $575 for a monthly dose and $1,725 for a quarterly dose, and will be made available in just over a week’s time.

Brendan O’Grady, Executive Vice President and Head of North America Commercial at Teva, added: “Today’s approval is an important step forward for Teva and the migraine community. Our entire organisation is proud to bring this new biologic product forward at a responsible price, and we are eager to work with insurers to encourage coverage that provides full access and availability in this much needed category.”

Matt Fellows

Comments

If you want to play some mind twisting game then from here you will play spades free online with all unlocked level without any pay and download the goal in the spades is to score more points than your rival.

You have some good experience with many things. I watch your videos on different places and I hope you continue it for us. Finding the best automatic cat feeder in 2020

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches